Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2003
06/12/2003WO2003048122A2 Inhibitors of cytosolic phospholipase a2
06/12/2003WO2003047626A1 Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
06/12/2003WO2003047569A1 Compositions and methods for inhibiting prenyltransferases
06/12/2003WO2003047520A2 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
06/12/2003WO2003047517A2 Novel-n-[4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa
06/12/2003WO2003047516A2 Pyrimidine compounds
06/12/2003WO2003047513A2 Method for treating ocular hypertension
06/12/2003WO2003047417A2 Ep4 receptor agonist, compositions and methods thereof
06/12/2003WO2003032994A3 Novel tri-substituted pyrimidines, method for production and use thereof as medicament
06/12/2003US20030109609 Thioimidazolidine derivatives as light stabilizers for polymers
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109556 Melanocortin receptor ligands
06/12/2003US20030109550 Substituted indazole compounds for the treatment of inflammation
06/12/2003US20030109545 Their solvates and/or hydrates exhibiting an affinity and a selectivity for arginine-vasopressin V1b receptors or for both V1b and V1a receptors.
06/12/2003US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2
06/12/2003US20030109533 New benzenesulphonamide compounds
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109518 Substituted 1,4-benzodiazepines and uses thereof
06/12/2003US20030108486 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
06/12/2003CA2672549A1 Amorphous and crystalline forms of losartan potassium and process for their preparation
06/12/2003CA2468846A1 Peroxisome proliferator activated receptor agonists
06/12/2003CA2468349A1 Pyrimidine compounds
06/12/2003CA2466757A1 Method for treating ocular hypertension
06/12/2003CA2466751A1 Ep4 receptor agonist, compositions and methods thereof
06/12/2003CA2465597A1 Amorphous and crystalline forms of losartan potassium and process for their preparation
06/11/2003EP1318147A1 Novel pyrimidine derivative and novel pyridine derivative
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317446A1 Oxindole derivatives
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317429A1 Amidine inhibitors of serine proteases
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP0892787B1 Novel alpha-hydroxylic acid derivatives, their production and use
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/10/2003US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser
06/10/2003US6576652 Administering substituted imidazoles, particular by losartan potassium, treatment of post-transplant hypertension.
06/10/2003US6576631 Broad disease control spectrum; residual effectiveness, rainfastness; nondamaging to crops
06/10/2003CA2232775C Acyl compounds
06/05/2003WO2003045941A1 Pyridine and pyrimidine derivatives
06/05/2003WO2003045939A1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045924A1 Substituted aryl 1,4-pyrazine derivatives
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045395A1 Quinazoline derivatives for the treatment of t cell mediated diseases
06/05/2003WO2003045381A1 Aminoalkylimidazole derivatives and their use in medicine
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2003045307A2 Pharmaceutical formulations comprising indolinone derivatives
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105279 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/05/2003US20030105151 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105143 Bactericides, antiseptics, cosmetics, cleaning compounds, enhaned oil recovery, papermaking
06/05/2003US20030105139 Indole derivatives as 5-HT receptor antagonist
06/05/2003US20030105119 For therapy of inflammation, immune disorders, asthma, chronic obstructive pulmonary disease (COPD), multiple sclerosis (MS), inflammatory bowel disease (IBD); side effect reduction
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105105 As anticoagulant agents for therapy and prophylaxis of thromboembolic disorders
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105081 Heterocyclic compounds as ligands of the GABAA receptor
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104324 Yellow coupler and silver halide color photographic lightsensitive material containing the same
06/05/2003CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2467870A1 Substituted aryl 1,4-pyrazine derivatives
06/05/2003CA2466807A1 Pharmaceutical formulations comprising indolinone derivatives
06/04/2003EP1316313A2 Composition for the treatment of ischemic stroke containing zonampanel and a tissue plasminogen activator
06/04/2003EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
06/04/2003EP1315716A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315715A1 Quinazoline derivatives as kinase inhibitors
06/04/2003EP1315698A1 Pyrrolidines as inhibitors of neuraminidases
06/04/2003EP1155014B1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
06/04/2003EP1017395A4 Method for treating premenstrual or late luteal phase syndrome
06/04/2003EP0967210B1 Process for preparing biologically active derivatives of 1,2,4-triazol and intermediaries useful in this process
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones
06/04/2003EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
06/04/2003EP0775135B1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003CN1422266A Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/04/2003CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110486C Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/03/2003USRE38133 Kappa agonist compounds and pharmaceutical formulations thereof
06/03/2003USRE38132 Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
06/03/2003US6573377 Antitumor agent capable of showing its efficacy even against 5- FU drug resistant tumors
06/03/2003US6573293 Anticancer agents
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573266 Piperazine derivatives and their use as anti-inflammatory agents
06/03/2003US6573262 Compounds for treating mammals infected with HIV virus
06/03/2003CA2413491A1 Treatment for ischemic stroke
1 ... 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 ... 626